Merck Signs Nearly $500 Million Licensing Deal With Austria-Based Cyprumed For Tablet-Based Peptide Delivery – Merck & Co (NYSE:MRK)
Merck & Co Inc MRK and privately held Cyprumed GmbH signed a non-exclusive license and option agreement on…
Browsing Tag